Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 2009 Nov 10;106(45):19150–19155. doi: 10.1073/pnas.0909293106

Rescue of radiation-induced cognitive impairment through cranial transplantation of human embryonic stem cells

Munjal M Acharya a, Lori-Ann Christie b, Mary L Lan a, Peter J Donovan c, Carl W Cotman b, John R Fike d, Charles L Limoli a,1
PMCID: PMC2776427  PMID: 19901336

Abstract

Cranial irradiation remains a frontline treatment for the control of tumor growth, and individuals surviving such treatments often manifest various degrees of cognitive dysfunction. Radiation-induced depletion of stem/precursor cell pools in the brain, particularly those residing in the neurogenic region of the hippocampus, is believed, in part, to be responsible for these often-unavoidable cognitive deficits. To explore the possibility of ameliorating radiation-induced cognitive impairment, athymic nude rats subjected to head only irradiation (10 Gy) were transplanted 2 days afterward with human embryonic stem cells (hESC) into the hippocampal formation and analyzed for stem cell survival, differentiation, and cognitive function. Animals receiving hESC transplantation exhibited superior performance on a hippocampal-dependent cognitive task 4 months postirradiation, compared to their irradiated surgical counterparts that did not receive hESCs. Significant stem cell survival was found at 1 and 4 months postirradiation, and transplanted cells showed robust migration to the subgranular zone throughout the dentate gyrus, exhibiting signs of neuron morphology within this neurogenic niche. These results demonstrate the capability to ameliorate radiation-induced normal tissue injury using hESCs, and suggest that such strategies may provide useful interventions for reducing the adverse effects of irradiation on cognition.

Keywords: cognition, stem cells, radiotherapy


Exposure of the brain to ionizing radiation occurs under a variety of clinical situations, and is an important adjuvant treatment for primary and metastatic brain tumors, head and neck cancers, and central nervous system leukemias/lymphomas. While radiotherapy is the single most effective treatment after surgical resection (1), the dose that can be safely administered is limited by the tolerance of normal brain tissue. Typical doses for whole or partial brain irradiation can exceed 50 Gy (2, 3), while more spatially constrained procedures (e.g., LINAC-based or gamma knife radiosurgery) can deposit single doses well in excess of 15 Gy to normal tissue at the tumor margins (4). While recent advances in dose delivery have minimized overt tissue injury, less severe morphologic injury can occur at these and much lower doses, resulting in variable degrees of cognitive dysfunction in both pediatric and adult patients (5–8). While radiation-induced cognitive deficits have a varied character, they often include significant impairments in hippocampus-dependent function such as learning, memory, and spatial information processing (9–11).

The hippocampus is one of two active sites of neurogenesis in the mammalian brain (12), and stem/precursor cell proliferation in the subgranular zone (SGZ) of the dentate gyrus generates cells that migrate to the granule cell layer (GCL) and differentiate into mature neuronal and glial phenotypes (13). Significant work has now demonstrated that these newly born neurons develop granule cell morphology and express mature neuronal markers (14), project connections to their normal CA3 target region and develop action potentials and synaptic inputs (15, 16). Further evidence supporting the functionality of these newly born neurons include data showing that changes in neurogenesis are positively correlated with changes in cognition (17–19). Insults such as irradiation (20), inflammation (21, 22), and stress (23) inhibit neurogenesis and elicit cognitive declines, while manipulations of the redox microenvironment (24), the use of anti-inflammatory agents (25) or environmental enrichment (26) upregulate neurogenesis and can ameliorate, at least in part, these cognitive dysfunctions. While the extent and precise mechanisms by which new neurons functionally impact hippocampal-dependent processes remains uncertain, it seems likely that strategies capable of augmenting neuronal cell numbers in the hippocampus may provide an avenue for rescuing certain cognitive deficits brought on by the inhibition of neurogenesis and/or attrition of granule cell neurons.

Regenerative medicine holds great promise for the treatment of a variety of ailments, but to date, the only routine application for stem cell therapy involves hematopoietic stem cell transplantation for the treatment of leukemias and lymphomas (27). Bone marrow-derived stem cells that are capable of reconstituting the immune system after irradiation (27), have also been found to facilitate the repair of brain injury in rodent models (28). A number of stem and progenitor cell types have been proposed for the treatment of neurological diseases including neural, bone marrow, umbilical cord, and embryonic stem cells (29, 30). Many of these approaches have been used successfully in animal models to ameliorate degenerative conditions such as Alzheimer's (31, 32), Parkinson's (33, 34), and Huntington's (35) disease, as well as other disorders such as epilepsy (36–38), excitotoxic brain damage (39), and traumatic brain injury (40). While a recent laboratory study has demonstrated the efficacy of transplanting salivary stem cells to alleviate radiation-induced xerostomia (41), with the exception of the bone marrow, the application of stem cell therapies to reduce radiation-induced normal tissue damage is still in its infancy. Ultimately, the success (or failure) of such approaches will depend on the functional engraftment of transplanted cells into the irradiated tissue bed. In the CNS, irradiation triggers a complex and multifactorial response involving persistent increases in oxidative species and inflammatory cytokines that actively participate in the remodeling of the irradiated microenvironment (42, 43). The protracted nature of the CNS radiation response contributes to the inhibition of endogenous neurogenesis (21, 44) and impairs the differentiation of neural precursor cells when transplanted into the irradiated brain (45). Such changes are not however, irreversible (44), and here we report that human embryonic stem cells (hESCs) transplanted into the hippocampus can rescue cognitive impairment caused by irradiation, thereby providing evidence that these pluripotent cells can be used to improve radiation-induced normal tissue injury.

Results

In Vitro and in Vivo Immunostaining of hESCs.

Before transplantation, hESCs were maintained on matrigel in an undifferentiated state. Pluripotency of hESCs was verified by immunostaining for Oct-4 (transcription factor Octamer-4) and SSEA-4 (glycolipid surface - Stage Specific Embryonic Antigen-4), and under our culture conditions, cells showed abundant expression of these markers (Fig. 1 A–D). For the studies presented, hESCs were used at passages 42–49.

Fig. 1.

Fig. 1.

Pluripotency markers in hESCs. Immunocytochemical analysis of hESCs counter-stained with DAPI (A) shows strong expression and colocalization of the pluripotent markers Stage Specific Embryonic Antigen, (SSEA-4, B), and transcription factor Octamer-4, (Oct-4, C), shown as merged image (D). Colabeling of BrdU (red) and human specific nuclear antigen (green) in vitro (E) and in vivo (F) confirm the correspondence between BrdU labeled hESC and the presence of a specific human antigen. Orthogonal images (E and F) represent 3-D reconstructions of 1-μm confocal sections, and (F) were derived from a coronal section of a rat brain grafted with hESCs 4 months prior. (G) Schematic illustration of transplantation studies. Two-month-old athymic nude rats given 10 Gy head-only irradiation were grafted with hESC 2 days post-irradiation. At 4 months following these procedures, animals were subjected to cognitive testing then euthanized for the determination of transplanted cell survival and differentiation. A cohort of animals that did not undergo cognitive testing was also euthanized at 1 month post-transplant for survival and differentiation studies. (Scale bars, 200 μm in A–D; 2 μm in E; and 4 μm in F).

To trace hESCs after grafting, hESCs were labeled in vitro with BrdU before transplantation. In vitro controls verified the colabeling of hESCs with BrdU and a human specific nuclear antigen (Fig. 1E). These labels were also used to verify the presence of the BrdU positive human cells in tissue sections of animals engrafted with hESCs (Fig. 1F). The correspondence between cells colabeled with BrdU and human specific markers indicated that grafted cells did not undergo significant proliferation postgrafting, and validates these markers for tracking of grafted hESCs in the host tissue. A schematic representation of our study is illustrated in Fig. 1G.

Transplanted hESCs Rescue Cognitive Deficits.

Four months postgrafting, rats were habituated and trained on a novel place recognition task (NPR). The NPR task uses the innate tendency of rats to explore novelty. First, rats are exposed to two identical objects in specific spatial locations within a test arena. Following a retention interval, one of the objects is moved to a new spatial location and rats are placed in the test arena again. Rats that remember the previous spatial arrangement of the objects will spend more time exploring the object that has been moved to the novel spatial location. Successful performance of the task has been shown to rely on intact hippocampal function (46, 47).

As expected, irradiated rats (IRR) showed impaired novel place recognition at the short, 5-min retention interval. Irradiated animals spent significantly less time exploring the novel place compared to control animals (Fig. 2A). In contrast, after the 5-min retention interval, irradiated, hESC-transplanted rats (IRR+hESC) did not differ from control animals and spent more time than expected by chance (indicated by the dashed line in Fig. 2A) exploring the novel spatial location (Fig. 2A). Similar trends were observed in terms of total time spent exploring the novel spatial location (Fig. 2B), and in frequency of visits to the novel spatial location and latency to explore the novel spatial location. These results suggested that hESC transplantation attenuated post-irradiation cognitive impairments and preserved short-term memory for spatial information in a hippocampal-dependent task.

Fig. 2.

Fig. 2.

Human embryonic stem cell implantation improves radiation-induced impairments in novel place recognition (NPR). Rats were first familiarized with two identical objects in specific spatial locations in an open field, and total time spent exploring was assessed. Following a 5-min retention interval, they were re-presented with the same objects with one moved to a novel spatial location. (A) Irradiated animals (IRR) spent a significantly lower proportion of time exploring the novel place [ANOVA, P = 0.031, FPLSD, P < 0.015 vs. controls (Con) and vs. hESC-implanted controls (Con+hESC)]. In contrast, irradiated animals that received hESC injections (IRR+hESC) did not differ from either control group (P >0.25), and spent more time exploring the novel place than expected by chance (dashed line at 50%) although the latter was not found to be statistically significant (one sample t-test, P = 0.364). Nonetheless, the fact that the IRR+hESC group did not differ from controls suggests that performance was partially restored following hESC grafting. Twenty-four hours after the initial familiarization phase, rats were again presented with the same two objects, with one moved to a new spatial location. After the 24-h retention interval, (C) animals in the IRR group spent a significantly lower proportion of time exploring the novel place (ANOVA, P = 0.042, FPLSD, P = 0.007 vs. Con). In contrast, IRR+hESC animals did not differ from controls (P = 0.208). The results suggest that hESC transplantation partially rescued radiation-induced deficits on hippocampal dependent NPR task. Similar trends were observed when total time spent exploring the novel place was assessed after both the 5-min (B) and 24-h (D) retention intervals. Analysis of time spent exploring both objects during the initial familiarization phase revealed that IRR animals tended to spend less time engaged in exploration than both the Con and IRR+hESC group (E, ANOVA, P = 0.026, FPLSD, P = 0.068 vs. Con and P = 0.004 vs. IRR+hESC), which may partially explain why they showed impairments in NPR following the retention intervals. Data are presented as means + 1 S.E.M.

At the 24-h retention interval, IRR rats again showed impaired NPR compared to control animals (Fig. 2C). By contrast, IRR+hESC rats did not differ significantly from control animals. However, IRR+hESC animals did not spend more time than expected by chance exploring the novel spatial location. Again, we observed similar trends when we analyzed total exploration of the novel spatial location (Fig. 2D), as well as frequency of visits and latency to first explore the novel location. The results suggest that hESC transplantation may also improve long-term retention of spatial information, although the treatment appeared to be more effective at the shorter, 5-min retention interval. During the 24-h test phase only, control animals receiving hESCs spent significantly less time exploring the novel place compared to controls receiving vehicle injections (Fig. 2C). This result suggests that hESC implantation in control animals disrupts long-term but not short-term recognition memory, although further behavioral testing is necessary to confirm this finding. These data suggest that in the intact hippocampus, hESC transplantation may have a distinct dose-response (i.e., cell number) or may actually disrupt hippocampal function as compared to an irradiated microenvironment that might be more conducive to integration of grafted hESCs.

To better understand why IRR animals showed impaired short- and long-term NPR abilities, we analyzed total time spent exploring both objects during the familiarization phase given before the retention intervals. We found a significant difference between the groups; IRR animals tended to spend less time exploring during the familiarization phase compared to both the control and IRR+hESC animals (Fig. 2E). This result suggested that the impairments seen in the IRR animals at 5min and 24 h post-familiarization might be related to lower exploration during initial exposure to the objects.

Location and Migration of hESCs in the Irradiated Rat Hippocampus.

At 4 months posttransplant and after cognitive testing, animals in each group were euthanized for immunocytochemical analyses. An additional cohort of animals not subjected to cognitive tests was analyzed at 1 month post-transplant, to assess early patterns of incorporation and differentiation of the grafted hESCs. An examination of BrdU immunostained sections from animals that received transplants revealed that the majority of grafted cells were located within the hippocampal formation and adjacent to the CA1 subfield and corpus callosum (Fig. 3). Representative sections showed the intrahippocampal location of grafted hESCs at 1 (Fig. 3 A–C) and 4 months post-transplant (Fig. 3 D–F). Similar localization and migration patterns of hESCs were found at both post-transplant times in all animals receiving grafts. Moreover, the data show that grafted hESCs migrated extensively into the dentate gyrus (DG), hilus (DH), and hippocampal CA1 subfield, (Fig. 3). In both irradiated and unirradiated animals, grafted hESC were also found to exhibit significant homing to the SGZ, populating this neurogenic niche throughout the septo-temporal axis of the host hippocampus.

Fig. 3.

Fig. 3.

Survival and intrahippocampal location of transplanted hESCs. At 1 month postgrafting, hESCs are shown to incorporate extensively throughout the host-hippocampus (magnification, ×5–20 in A–C). Qualitatively similar patterns of migration were observed at 4 months post-grafting, albeit lower hESC numbers were evident (magnification, ×5–20 in D–F). Grafted cells were detected by BrdU immunostaining (dark brown nuclei) and counterstained with haematoxylin. Transplanted hESCs migrated extensively from the site of injection throughout the hippocampal formation (dentate gyrus, DG, dentate hilus, DH, granule cell layer, GCL, and CA1) and partially in the corpus callosum. Images shown were derived from irradiated animals. (Scale bars, 200 μm in A and D; 100 μm in B and E; and 50 μm in C and F.

Neural Differentiation of Transplanted hESCs.

To analyze the differentiation of engrafted hESCs, dual immunofluorescence and Z-section analyses using confocal microscopy were performed on representative sections at 1 and 4 month post-transplant. Analysis of BrdU colabeling with NeuN or GFAP demonstrated that a portion of cells showed neural and astrocytic differentiation at both posttransplant times in all animals that received hESC grafting. Grafted cells positive for both BrdU and NeuN displayed mature neuronal morphology (Fig. 4A, B, E, and F). Grafted cells expressing these neuronal markers were predominately found at the SGZ, as opposed to other hippocampal subfields. Assessment of astrocytic differentiation via BrdU and GFAP dual immunofluorescence revealed the presence of GFAP positive astrocytes at each posttransplant time analyzed (Fig. 4 C, D, G, and H). Grafted cells expressing astrocytic phenotypes were uniformly distributed throughout the hippocampus, with no apparent preference for a particular hippocampal region.

Fig. 4.

Fig. 4.

Differentiation of transplanted hESCs. At 1 month post-grafting (A–D), BrdU (red) positive hESCs were observed to differentiate into mature neurons (A and B) or astrocytes (C and D) as indicated by the colabeling of the neuron-specific nuclear antigen (NeuN, green) or glial fibrillary acidic protein (GFAP, green). Similar phenotypes were found 4 months post-grafting (E–H), where BrdU (red)-positive cells were also found to express markers of mature neurons (NeuN, E and F) and astrocytes (GFAP, G and H). Orthogonal reconstructions of BrdU+/NeuN+ colabeled cells (B and F) and BrdU+/GFAP+ colabeled cells (D and H) are shown at each post-grafting time. Images shown were derived from irradiated animals. (Scale bars, 20 μm in A and E; 50 μm in C and G; and 20 μm in B, D, F, H.)

Discussion

The data presented here show that transplantation of hESCs into the hippocampal formation can impact the development of radiation-induced cognitive impairment. While some data exist showing that such impairments can be ameliorated in part by voluntary running (26), this report shows that hESC transplantation can be effectively used to reduce a serious complication of cranial irradiation. The mechanism of this cell-mediated effect is not yet clear, and whether it depends on cell replacement per se, as opposed to trophic support provided by the transplanted cells, remains to be determined. In the present study, we were able to show that at both 1 and 4 months post-transplantation, hESC cells expressed neuronal and astrocytic markers. Significant survival and migration of the transplanted cells to the SGZ were observed at 1 and 4 months post-irradiation, with greater survival found at 1 month. There was a greater likelihood for the fraction of cells migrating to the SGZ to develop mature neuronal phenotypes compared to those cells residing in non-neurogenic regions. Whether those cells were actually integrated into hippocampal circuits is not yet known. Regarding trophic support, studies of ischemic injury found transplanted neural stem/precursor cells to be neuroprotective via glial cell line-derived neurotrophic factor (GDNF) (48, 49). Other work using a transgenic model of Alzheimer disease provided evidence that brain-derived neurotrophic factor (BDNF) from transplanted rodent neural stem cells (mNSC) played a significant role in restoring certain cognitive deficits when assessed 1-month posttransplantation (31). Regardless of the manner in which the transplanted pluripotent cells functioned in this study, their mere presence seemed to ameliorate the adverse effects of ionizing irradiation on cognition.

We elected to use the novel place recognition (NPR) task to assess the effects of hippocampal hESC transplantation, as successful performance on the task has been shown to depend on intact hippocampal function (46, 47). Our behavioral studies have corroborated a number of past reports linking radiation-induced alterations in cognition to impaired hippocampal neurogenesis (9, 10), and have extended them by showing that irradiation causes significant short- and long-term memory impairments on the NPR task in rats. Irradiated animals that received vehicle injections exhibited significantly impaired NPR compared to unirradiated controls ± hESC, suggesting their short- (5-min) and long-term (24-h) memory for the former spatial arrangement of the objects was impaired (Fig. 2). Transplantation of hESC into irradiated animals (IRR+hESC) was found to reduce postirradiation cognitive impairments. At short (5-min) and long (24-h) retention intervals, animals that received IRR+hESC did not differ significantly from unirradiated controls ± hESC, suggesting that hESC restored NPR to at least levels intermediate between the control and IRR groups. Animals that received IRR+hESC showed a trend to spend more time exploring the novel spatial location than expected by chance (5min test), suggesting preservation of short-term memory. Further, in the irradiated groups, the duration and frequency of exploration of the novel place was significantly higher in animals transplanted with hESC versus vehicle (t-tests; P <0.05). However, more rigorous testing using additional hippocampal-dependent tasks such as the Morris water maze (50, 51) or contextual fear conditioning (52) may provide more information about the robustness of our observed effect, and possibly about its underlying cause.

The cells used for transplantation were pluripotent, at least based on marker expression (Oct4, SSEA4, Fig. 1) in vitro, and the BrdU labeling indices of those cells was approximately 98%. Additionally, there was a one-to-one correspondence between cells staining positive for the BrdU label and the human specific nuclear antigen (Fig. 1). While the survival of the transplanted cells was qualitatively greater at 1 month than at 4 months after transplantation, there were still large numbers of BrdU+ cells at the later time point (Fig. 3). Further, those cells had migrated pervasively throughout the hippocampus and seemed to be predominantly located in or near the dentate SGZ (Figs. 3 and 4). It was of particular interest that the transplanted cells near the SGZ showed morphologic changes consistent with mature neurons while those at the site of transplantation were more glial in nature. This suggests that the neurogenic niche had some influence on the morphologic character of the cells, although exactly how is not known. It is also worth noting that no overt adverse cognitive sequelae (e.g., ataxia) were observed in the cohort of animals receiving hESC grafting (Con/IRR+hESC), suggesting that intracranial teratogenesis was not problematic, although this was not tested for directly.

While transplantation of stem cells for the therapeutic management of disease and degenerative conditions may one day be realized, this approach has to be considered in the context of a number of potential limitations, including immunorejection (53), teratogenesis and tumorigenesis (54), and ethical debates (55). Recent advances in generating induced pluripotent stem cells (iPS) may alleviate some of these concerns (56), but considerable work is still needed to determine if a transplantation effect, such as that shown here, is a viable option for use in humans. Regardless, the data shown here constitutes a finding that transplanted hESCs can survive, differentiate along neuronal lineages, and ameliorate cognitive impairments after cranial irradiation. These data are encouraging and offer the promise of tailoring other stem cell strategies for minimizing the adverse side effects associated with exposure to ionizing radiation.

Materials and Methods

Animals and Irradiation.

Young (2-month-old) athymic nude rats acquired from National Cancer Institute (strain 02N01 Cr:NIH-rnu) were used in this study. All animal procedures were performed in strict accordance with the National Institutes of Health and Institutional IACUC guidelines. Anesthetized rats were subjected to head only γ-irradiation (10 Gy) using a 137Cs irradiator (J.L. Shepard and Associates Mark I) at the dose rate of 2.07 Gy/min. Growth and characterization of hESC and the processing of all tissue sections followed standard procedures (see SI Methods for further details).

Intrahippocampal Transplantation of hESCs.

Rats received bilateral intrahippocampal injections of BrdU labeled hESCs 48 h after cranial or sham irradiation. 1.0 × 105 live cells were injected in 1 μL of the cell suspension using a 5-μL Hamilton microsyringe (33-gauge) at an injection rate of 0.25 μL/min. Each hippocampi received four distinct graft injections using the following stereotaxic coordinates: (i) AP: 3.0 mm from bregma, ML: 1.8 mm from midline, and ventral DV: 3.2 mm from the surface of the brain; (ii) AP: 3.6 mm, ML: 2.5 mm, DV: 3.2 mm; (iii) AP: 4.2 mm, ML: 3.2 mm, DV: 3.2 mm and (iv) AP: 4.8 mm, ML: 4.0 mm, DV: 3.2 mm. Thus, the hippocampus of each hemisphere received a total of 4.0 × 105 live hESCs. Control and irradiated rats receiving vehicle (sterile conditioned medium) at the same stereotaxic coordinates served as sham surgery groups.

Behavioral Analysis.

At 4 months post-grafting, a blinded observer examined rats in all groups [control (Con+hESC) and irradiated (IRR+hESC) rats receiving hESC grafts, control (Con) and irradiated (IRR) rats receiving sham surgery and vehicle injections], for hippocampal-dependent spatial memory using a novel place recognition (NPR) task according to a standard protocol (46) (SI Methods).

Measures and Analyses.

Exploration ratio, or the percentage of total exploration time spent exploring the novel spatial location (tnovel/tnovel+tfamiliar) was used as the main dependent measure. We chose to analyze the behavior of the animals during minute 1 of the 3-min, 5-min, and 24-h test phases because previous research has shown that preference for the novel place diminishes after the first minute, as the spatial locations become equally familiar to the animals (46). For completeness, repeated measures ANOVA that included all data from each of the three test sessions were performed. These analyses confirmed our behavioral findings found during the first minute. We also analyzed the total time, frequency of visits, and latency to first explore the novel place during the test phases. Additionally, time spent exploring both familiar places was recorded during the familiarization phase.

Exploration ratio data were analyzed using univariate ANOVAs for the 5-min and 24-h test phases (PASW Statistics version 17.0, SPSS Inc.). When a statistically significant (i.e., P ≤ 0.05) overall group effect was found, Fisher Protected Least Significant Difference (FPLSD) post hoc tests were run to compare the four groups.

Acknowledgments.

We thank Drs. Aileen J. Anderson and Brian J. Cummings for their help in defining stereotactic coordinates and other methodological details and Christina Tu for her technical assistance in the growth and characterization of hESCs. This work was supported by California Institute of Regenerative Medicine Seed Grant RS1-00413 (to C.L.L.) and National Institutes of Health Grants AG 00538 and AG 16573 (to C.W.C.) and RO1 HD49488 and PO1 HD47675 and California Institute of Regenerative Medicine Grant RC1-00110 (to P.J.D.).

Footnotes

The authors declare no conflict of interest.

This article is a PNAS Direct Submission.

This article contains supporting information online at www.pnas.org/cgi/content/full/0909293106/DCSupplemental.

References

  • 1.Walker MD, Strike TA, Sheline GE. An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys. 1979;5:1725–1731. doi: 10.1016/0360-3016(79)90553-4. [DOI] [PubMed] [Google Scholar]
  • 2.Sheline GE, Wara WM, Smith V. Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys. 1980;6:1215–1228. doi: 10.1016/0360-3016(80)90175-3. [DOI] [PubMed] [Google Scholar]
  • 3.Tofilon PJ, Fike JR. The radioresponse of the central nervous system: A dynamic process. Radiat Res. 2000;153:357–370. doi: 10.1667/0033-7587(2000)153[0357:trotcn]2.0.co;2. [DOI] [PubMed] [Google Scholar]
  • 4.Shaw E, et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: Final report of RTOG protocol 90–05. Int J Radiat Oncol Biol Phys. 2000;47:291–298. doi: 10.1016/s0360-3016(99)00507-6. [DOI] [PubMed] [Google Scholar]
  • 5.Butler J, Rapp S, Shaw E. Managing the cognitive effects of brain tumor radiation therapy. Curr Treat Options Oncol. 2006;7:517–523. doi: 10.1007/s11864-006-0026-5. [DOI] [PubMed] [Google Scholar]
  • 6.Meyers CA, Brown PD. Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors. J Clin Oncol. 2006;24:1305–1309. doi: 10.1200/JCO.2005.04.6086. [DOI] [PubMed] [Google Scholar]
  • 7.Roman DD, Sperduto PW. Neuropsychological effects of cranial radiation: Current knowledge and future directions. Int J Radiat Oncol Biol Phys. 1995;31:983–998. doi: 10.1016/0360-3016(94)00550-8. [DOI] [PubMed] [Google Scholar]
  • 8.Surma-aho O, et al. Adverse long-term effects of brain radiotherapy in adult low-grade glioma patients. Neurology. 2001;56:1285–1290. doi: 10.1212/wnl.56.10.1285. [DOI] [PubMed] [Google Scholar]
  • 9.Raber J, et al. Radiation-induced cognitive impairments are associated with changes in indicators of hippocampal neurogenesis. Radiat Res. 2004;162:39–47. doi: 10.1667/rr3206. [DOI] [PubMed] [Google Scholar]
  • 10.Rola R, et al. Radiation-induced impairment of hippocampal neurogenesis is associated with cognitive deficits in young mice. Exp Neurol. 2004;188:316–330. doi: 10.1016/j.expneurol.2004.05.005. [DOI] [PubMed] [Google Scholar]
  • 11.Winocur G, Wojtowicz JM, Sekeres M, Snyder JS, Wang S. Inhibition of neurogenesis interferes with hippocampus-dependent memory function. Hippocampus. 2006;16:296–304. doi: 10.1002/hipo.20163. [DOI] [PubMed] [Google Scholar]
  • 12.Gage FH. Mammalian neural stem cells. Science. 2000;287:1433–1438. doi: 10.1126/science.287.5457.1433. [DOI] [PubMed] [Google Scholar]
  • 13.Palmer TD, Takahashi J, Gage FH. The adult rat hippocampus contains primordial neural stem cells. Mol Cell Neurosci. 1997;8:389–404. doi: 10.1006/mcne.1996.0595. [DOI] [PubMed] [Google Scholar]
  • 14.Cameron HA, Woolley CS, McEwen BS, Gould E. Differentiation of newly born neurons and glia in the dentate gyrus of the adult rat. Neuroscience. 1993;56:337–344. doi: 10.1016/0306-4522(93)90335-d. [DOI] [PubMed] [Google Scholar]
  • 15.Markakis EA, Gage FH. Adult-generated neurons in the dentate gyrus send axonal projections to field CA3 and are surrounded by synaptic vesicles. J Comp Neurol. 1999;406:449–460. [PubMed] [Google Scholar]
  • 16.van Praag H, et al. Functional neurogenesis in the adult hippocampus. Nature. 2002;415:1030–1034. doi: 10.1038/4151030a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Kempermann G, Kuhn HG, Gage FH. More hippocampal neurons in adult mice living in an enriched environment. Nature. 1997;386:493–495. doi: 10.1038/386493a0. [DOI] [PubMed] [Google Scholar]
  • 18.Kempermann G, van Praag H, Gage FH. Activity-dependent regulation of neuronal plasticity and self repair. Prog Brain Res. 2000;127:35–48. doi: 10.1016/s0079-6123(00)27004-0. [DOI] [PubMed] [Google Scholar]
  • 19.Song H, et al. New neurons in the adult mammalian brain: Synaptogenesis and functional integration. J Neurosci. 2005;25:10366–10368. doi: 10.1523/JNEUROSCI.3452-05.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Mizumatsu S, et al. Extreme sensitivity of adult neurogenesis to low doses of X-irradiation. Cancer Res. 2003;63:4021–4027. [PubMed] [Google Scholar]
  • 21.Fike JR, Rola R, Limoli CL. Radiation response of neural precursor cells. Neurosurg Clin N Am. 2007;18:115–127. doi: 10.1016/j.nec.2006.10.010. [DOI] [PubMed] [Google Scholar]
  • 22.Rola R, et al. High-LET radiation induces inflammation and persistent changes in markers of hippocampal neurogenesis. Radiat Res. 2005;164:556–560. doi: 10.1667/rr3412.1. [DOI] [PubMed] [Google Scholar]
  • 23.Leuner B, Gould E, Shors TJ. Is there a link between adult neurogenesis and learning? Hippocampus. 2006;16:216–224. doi: 10.1002/hipo.20153. [DOI] [PubMed] [Google Scholar]
  • 24.Rola R, et al. Lack of extracellular superoxide dismutase (EC-SOD) in the microenvironment impacts radiation-induced changes in neurogenesis. Free Radic Biol Med. 2007;42:1133–1145. doi: 10.1016/j.freeradbiomed.2007.01.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Monje ML, Toda H, Palmer TD. Inflammatory blockade restores adult hippocampal neurogenesis. Science. 2003;302:1760–1765. doi: 10.1126/science.1088417. [DOI] [PubMed] [Google Scholar]
  • 26.Naylor AS, et al. Voluntary running rescues adult hippocampal neurogenesis after irradiation of the young mouse brain. Proc Natl Acad Sci USA. 2008;105:14632–14637. doi: 10.1073/pnas.0711128105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Greenberger JS, Epperly M. Bone marrow-derived stem cells and radiation response. Semin Radiat Oncol. 2009;19:133–139. doi: 10.1016/j.semradonc.2008.11.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Peister A, et al. Novel object recognition in Apoe(-/-) mice improved by neonatal implantation of wild-type multipotential stromal cells. Exp Neurol. 2006;201:266–269. doi: 10.1016/j.expneurol.2006.03.023. [DOI] [PubMed] [Google Scholar]
  • 29.Hess DC, Borlongan CV. Stem cells and neurological diseases. Cell Prolif. 2008;41:94–114. doi: 10.1111/j.1365-2184.2008.00486.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Le Belle JE, Svendsen CN. Stem cells for neurodegenerative disorders: Where can we go from here? BioDrugs. 2002;16:389–401. doi: 10.2165/00063030-200216060-00001. [DOI] [PubMed] [Google Scholar]
  • 31.Blurton-Jones M, et al. Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc Natl Acad Sci USA. 2009;106:13594–13599. doi: 10.1073/pnas.0901402106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Yamasaki TR, et al. Neural stem cells improve memory in an inducible mouse model of neuronal loss. J Neurosci. 2007;27:11925–11933. doi: 10.1523/JNEUROSCI.1627-07.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Meissner KK, Kirkham DL, Doering LC. Transplants of neurosphere cell suspensions from aged mice are functional in the mouse model of Parkinson's. Brain Res. 2005;1057:105–112. doi: 10.1016/j.brainres.2005.07.057. [DOI] [PubMed] [Google Scholar]
  • 34.Roy NS, et al. Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat Med. 2006;12:1259–1268. doi: 10.1038/nm1495. [DOI] [PubMed] [Google Scholar]
  • 35.Armstrong RJ, Watts C, Svendsen CN, Dunnett SB, Rosser AE. Survival, neuronal differentiation, and fiber outgrowth of propagated human neural precursor grafts in an animal model of Huntington's disease. Cell Transplant. 2000;9:55–64. doi: 10.1177/096368970000900108. [DOI] [PubMed] [Google Scholar]
  • 36.Acharya MM, Hattiangady B, Shetty AK. Progress in neuroprotective strategies for preventing epilepsy. Prog Neurobiol. 2008;84:363–404. doi: 10.1016/j.pneurobio.2007.10.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Boison D. Engineered adenosine-releasing cells for epilepsy therapy: Human mesenchymal stem cells and human embryonic stem cells. Neurotherapeutics. 2009;6:278–283. doi: 10.1016/j.nurt.2008.12.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Maisano X, et al. Embryonic stem cell-derived neural precursor grafts for treatment of temporal lobe epilepsy. Neurotherapeutics. 2009;6:263–277. doi: 10.1016/j.nurt.2009.01.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Mueller D, Shamblott MJ, Fox HE, Gearhart JD, Martin LJ. Transplanted human embryonic germ cell-derived neural stem cells replace neurons and oligodendrocytes in the forebrain of neonatal mice with excitotoxic brain damage. J Neurosci Res. 2005;82:592–608. doi: 10.1002/jnr.20673. [DOI] [PubMed] [Google Scholar]
  • 40.Riess P, et al. Embryonic stem cell transplantation after experimental traumatic brain injury dramatically improves neurological outcome, but may cause tumors. J Neurotrauma. 2007;24:216–225. doi: 10.1089/neu.2006.0141. [DOI] [PubMed] [Google Scholar]
  • 41.Lombaert IM, et al. Rescue of salivary gland function after stem cell transplantation in irradiated glands. PLoS One. 2008;3:e2063. doi: 10.1371/journal.pone.0002063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Limoli C, et al. Radiation response of neural precursor cells: Linking cellular sensitivity to cell cycle checkpoints, apoptosis and oxidative stress. Radiat Res. 2004;161:17–27. doi: 10.1667/rr3112. [DOI] [PubMed] [Google Scholar]
  • 43.Chiang CS, et al. Delayed molecular responses to brain irradiation. Int J Radiat Biol. 1997;72:45–53. doi: 10.1080/095530097143527. [DOI] [PubMed] [Google Scholar]
  • 44.Fike JR, Rosi S, Limoli CL. Neural precursor cells and central nervous system radiation sensitivity. Semin Radiat Oncol. 2009;19:122–132. doi: 10.1016/j.semradonc.2008.12.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Monje ML, Mizumatsu S, Fike JR, Palmer TD. Irradiation induces neural precursor-cell dysfunction. Nat Med. 2002;8:955–962. doi: 10.1038/nm749. [DOI] [PubMed] [Google Scholar]
  • 46.Mumby DG, Gaskin S, Glenn MJ, Schramek TE, Lehmann H. Hippocampal damage and exploratory preferences in rats: Memory for objects, places, and contexts. Learn Mem. 2002;9:49–57. doi: 10.1101/lm.41302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Save E, Buhot MC, Foreman N, Thinus-Blanc C. Exploratory activity and response to a spatial change in rats with hippocampal or posterior parietal cortical lesions. Behav Brain Res. 1992;47:113–127. doi: 10.1016/s0166-4328(05)80118-4. [DOI] [PubMed] [Google Scholar]
  • 48.Chen B, et al. Neuroprotective effect of grafting GDNF gene-modified neural stem cells on cerebral ischemia in rats. Brain Res. 2009;1284:1–11. doi: 10.1016/j.brainres.2009.05.100. [DOI] [PubMed] [Google Scholar]
  • 49.Kameda M, et al. Adult neural stem and progenitor cells modified to secrete GDNF can protect, migrate and integrate after intracerebral transplantation in rats with transient forebrain ischemia. Eur J Neurosci. 2007;26:1462–1478. doi: 10.1111/j.1460-9568.2007.05776.x. [DOI] [PubMed] [Google Scholar]
  • 50.Acevedo SE, McGinnis G, Raber J. Effects of 137Cs gamma irradiation on cognitive performance and measures of anxiety in Apoe-/- and wild-type female mice. Radiat Res. 2008;170:422–428. doi: 10.1667/rr1494.1. [DOI] [PubMed] [Google Scholar]
  • 51.Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods. 1984;11:47–60. doi: 10.1016/0165-0270(84)90007-4. [DOI] [PubMed] [Google Scholar]
  • 52.Villasana L, Rosenberg J, Raber J. Sex-dependent effects of (56)Fe irradiation on contextual fear conditioning in C57BL/6J mice. Hippocampus. 2009 doi: 10.1002/hipo.20659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Lui KO, Waldmann H, Fairchild PJ. Embryonic stem cells: Overcoming the immunological barriers to cell replacement therapy. Curr Stem Cell Res Ther. 2009;4:70–80. doi: 10.2174/157488809787169093. [DOI] [PubMed] [Google Scholar]
  • 54.Knoepfler PS. Deconstructing stem cell tumorigenicity: A roadmap to safe regenerative medicine. Stem Cells. 2009;27:1050–1056. doi: 10.1002/stem.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Daley GQ, et al. Ethics. The ISSCR guidelines for human embryonic stem cell research. Science. 2007;315:603–604. doi: 10.1126/science.1139337. [DOI] [PubMed] [Google Scholar]
  • 56.Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–676. doi: 10.1016/j.cell.2006.07.024. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES